SEC Form 4/A · accession 0001209191-16-110214
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Lewis Clayton Cantley Jr.
Director
Period of report
Nov 16, 2015
Accepted (ET)
Mar 23, 2016 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2,F3 | Nov 16, 2015 | S | 1,362 | $59.59 | D | 141,640 | D | |
| Common stockF2,F3,F4 | Nov 16, 2015 | S | 1,360 | $59.58 | D | 141,642 | I | See footnote |
| Common stockF5,F3 | Nov 17, 2015 | S | 3,490 | $59.99 | D | 138,150 | D | |
| Common stockF6,F3,F4 | Nov 17, 2015 | S | 3,492 | $59.98 | D | 138,150 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.21 to $61.78. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This form 4 is amended to include the sale of 149 and 147 shares of the Company's common stock by the reporting person and the reporting person's spouse, respectively, on November 16, 2015. The sale of these shares was also not reflected in the securities beneficially owned by the reporting person and the reporting person's spouse on the three subsequent forms 4 filed by the reporting person.
- F4Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- F5The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.24 to $61.52. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.23 to $61.76. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.